WHO pleas for rational antibiotic use in Asia as resistance worries mount
This article was originally published in Scrip
The Southeast Asia regional committee of the World Health Organization has made a call for the more rational use of antimicrobial agents, against a background of rising resistance problems and the emergence of "superbugs" in many countries in the area.
You may also be interested in...
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.
Collaboration with fundraising Tokyo-based venture builds mid-sized firm's interest in cell-based therapies in a highly supportive regulatory environment.